Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hong Kong Investigates Maker Of Diuretic Found To Have Fungus

This article was originally published in PharmAsia News

Executive Summary

Hong Kong's Department of Health is investigating drug maker Vickmans Laboratories after its diuretic Diurex (frusemide) was found to contain a fungus. Vickman was ordered to halt production and review its management process and procedures as the government collects evidence. The case could lead to a license suspension for the Hong Kong company if it is found to have allowed the aspergillus fungus in its drug. The department believes the fungus developed because the granules were held too long before being placed into tablets. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts